Main competitors
Dividend Yield (Y) Dividend Yield (Y+1) P/E (Y) Price to Book (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Capi.($)
- - - - - - - 58.6M
2.81%2.88%61.49x5.76x5x18.69x25.25x 298B
1.68%1.74%23.63x1.98x3.24x11.58x19.1x 69.4B
2.59%2.76%17.28x1.49x2.2x7.54x9x 8.6B
-.--%-.--%19.9x5.29x5.6x15.84x16.56x 3.93B
0.83%0.84%37.03x2.21x2.09x25.79x38.93x 3.34B
-.--%-.--%104.85x - - - - 2.71B
4.11%3.55%17.21x0.75x1.34x24.06x41.19x 1.06B
-.--%-.--%-7.38x12.16x202.44x-6.56x-5.12x 960M
Average 1.5% 1.47% 34.25x 4.24x 31.70x 13.85x 20.70x 43.15B
Weighted average by Cap. 2.53% 2.6% 53.12x 4.95x 5.08x 17.14x 23.78x
Specialty & Advanced Pharmaceuticals